We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $722M
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+97.69%
3 Year Est. Return
+317.96%
5 Year Est. Return
+499.45%
10 Year Est. Return
+3,067.75%
AUM
$2.29B
AUM Growth
+$97.3M
Cap. Flow
+$93.9M
Cap. Flow %
4.11%
Top 10 Hldgs %
24.25%
Holding
353
New
110
Increased
48
Reduced
90
Closed
94

Sector Composition

Rank Sector Weight
1 Healthcare 16.31%
2 Communication Services 13.14%
3 Technology 11.47%
4 Consumer Discretionary 9.93%
5 Financials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNCN
126
DELISTED
BNC Bancorp
BNCN
$2.93M 0.13%
187,374
-26,605
-12% -$444K
AGIO icon
127
Agios Pharmaceuticals
AGIO
$1.93B
$2.85M 0.12%
+46,483
New +$2M
RARE icon
128
Ultragenyx Pharmaceutical
RARE
$2.55B
$2.63M 0.12%
+46,482
New +$2.34M
C.WS.A
129
DELISTED
Citigroup Inc
C.WS.A
$2.57M 0.11%
2,700,985
-1,017,380
-27% -$792K
CPRI icon
130
Capri Holdings
CPRI
$1.74B
$2.33M 0.1%
32,700
HCBK
131
DELISTED
HUDSON CITY BANCORP INC
HCBK
$2.26M 0.1%
+232,434
New +$2.29M
R icon
132
Ryder
R
$10.1B
$2.08M 0.09%
23,170
-1,610
-6% -$144K
LAZ icon
133
Lazard
LAZ
$4.31B
$1.93M 0.08%
+38,119
New +$2M
SPNT icon
134
SiriusPoint
SPNT
$2.68B
$1.88M 0.08%
128,922
-296,828
-70% -$4.55M
CELG
135
DELISTED
Celgene Corp
CELG
$1.85M 0.08%
19,503
+16,303
+509% +$1.47M
RVNC
136
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.63M 0.07%
84,460
-500
-0.6% -$13K
AEGR
137
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.59M 0.07%
47,771
AR icon
138
Antero Resources
AR
$10.7B
$1.54M 0.07%
28,120
-52,110
-65% -$3.03M
NBIX icon
139
Neurocrine Biosciences
NBIX
$16.6B
$1.46M 0.06%
92,976
-32,024
-26% -$479K
HTGC icon
140
Hercules Capital
HTGC
$3.23B
$1.34M 0.06%
+92,976
New +$1.47M
IVR icon
141
Invesco Mortgage Capital
IVR
$805M
$1.24M 0.05%
7,916
-498
-6% -$85.2K
KMI icon
142
Kinder Morgan
KMI
$68.7B
$1.17M 0.05%
+30,427
New +$1.16M
DATA
143
DELISTED
Tableau Software, Inc.
DATA
$705K 0.03%
9,700
-225,600
-96% -$14.8M
PRU icon
144
Prudential Financial
PRU
$41.8B
$654K 0.03%
7,435
-50
-0.7% -$4.47K
DTV
145
DELISTED
DIRECTV COM STK (DE)
DTV
$519K 0.02%
6,000
-146,900
-96% -$12.6M
ASTI
146
DELISTED
ASCENT SOLAR TECHNOLOGIES INC COM STK
ASTI
$516K 0.02%
+233,303
New +$747K
CVC
147
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$497K 0.02%
+28,400
New +$526K
DOX icon
148
Amdocs
DOX
$6.22B
$496K 0.02%
10,800
+5,300
+96% +$248K
WLL
149
DELISTED
Whiting Petroleum Corporation
WLL
$496K 0.02%
21
+10
+91% +$255K
EA
150
DELISTED
Electronic Arts
EA
$495K 0.02%
13,900
+7,200
+107% +$262K

Similar funds

Zweig-DiMenna Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Zweig-DiMenna Associates held 353 positions worth $2.29B, up 4.4% from $2.19B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Zweig-DiMenna Associates deployed $93.9M of net new capital in Q3 2014, opening 110 new positions and adding to 48 existing holdings. Its largest new stake was Alibaba: 341,068 shares worth $30.3M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $42.1M trimmed.

  • Zweig-DiMenna Associates's largest Q3 2014 buy was Alibaba: 341,068 shares worth $30.3M.
  • Zweig-DiMenna Associates added most to Activision Blizzard in Q3 2014, an estimated $24M increase.
  • Zweig-DiMenna Associates's biggest Q3 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $42.1M.
  • Zweig-DiMenna Associates fully exited Humana in Q3 2014, selling an estimated $28M.
  • Zweig-DiMenna Associates's ten largest holdings make up 24% of its $2.29B portfolio in Q3 2014.
  • Zweig-DiMenna Associates opened 110 new positions and closed 94 in Q3 2014.
  • Zweig-DiMenna Associates's portfolio value rose 4.4% quarter-over-quarter to $2.29B.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2014, filed 10 Nov 2014.